Conventional imaging is suboptimal at evaluating disease status in renal cell carcinoma (RCC) because of poor sensitivity. Furthermore, there is an unmet need for the treatment of metastatic RCC, both ...
Background: Sunitinib malate is an oral, multitargeted tyrosine kinase inhibitor that has demonstrated superior efficacy over interferon (IFN)-α in a phase III trial in first-line, metastatic renal ...
Metastatic renal cell carcinoma (RCC) is a type of kidney cancer that has spread to other body parts. Depending on where it spreads, it can cause shortness of breath, bone pain, or jaundice. RCC is ...
Specificity of radiographic lymphadenopathy for lymph node metastasis in renal cell carcnioma. This is an ASCO Meeting Abstract from the 2015 Genitourinary Cancers Symposium. This abstract does not ...
Many patients with localized node-negative renal cell carcinoma (RCC) are elderly with competing comorbidities. Their overall survival benefit after surgical treatment is unknown. We reviewed cases in ...
Clear cell RCC is the most common histologic subtype of malignant tumors of the kidney. This histology accounts for 75% of renal masses that are evaluated. 7,8 Clear cell RCC derives from the proximal ...
Clear cell renal cell carcinoma (RCC) is the most common histological subtype of malignant kidney tumors. Clinically, clear cell RCC cannot be distinguished from other histological RCC classes based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results